Navigation Links
National grants further WA Medical Research
Date:10/30/2008

National grants totalling more than $6 million dollars have been awarded to the State's premier medical research facility, the Western Australian Institute for Medical Research (WAIMR), in support of a range of ground-breaking, world-first research projects.

Nine WAIMR scientists have shared 10 research grants from the National Health and Medical Research Council (NHMRC) and Australian Research Council (ARC) announced last week placing the Institute's success rate well above the rest of the State.

WAIMR Director Peter Klinken said he was delighted his team had achieved a strong result in this latest funding round and hoped its success would continue in future years.

"This is an excellent result I congratulate all the teams that have obtained grants this year the NHMRC and ARC are key sources of income for our researchers and this level of funding is crucial to the success of their work," he said.

"Consistently, we've been able to achieve great results from our funding applications this year half of all WAIMR researcher's grant applications were successful, which is twice the national average, and testament to the cutting-edge projects and brilliant minds we have here at the Institute.

"This funding allows our laboratories to take the next step forward in their research into the causes behind and finding cures for a number of chronic diseases, and offer benefit to all West Australians as well as the rest of the world.

"Dr Kevin Pfleger is leading a team that's showing it's among world-leaders in the field of molecular endocrinology and identifying drug targets after being awarded more than $800,000 in grants.

"For the second year running, our Head of Cancer Epidemiology, Associate Professor Lin Fritschi, secured $776,975 for a crucial study looking at a potential link between shift work and breast cancer.

"Another young WAIMR team is also making an impact, having scooped two grants Dr Aleksandra Filipovska and Dr Oliver Rackham will undertake important projects that look into the mitochondria including research that aims to improve chemotherapy treatments."

Professor Leon Flicker and Professor Osvaldo Almeida's team at WAIMR's WA Centre for Health and Ageing will share in a combined amount of more than $2.2 million for their ongoing work into healthy ageing.

Other WAIMR recipients of NHMRC and ARC research grants include:

  • Associate Professor Ruth Ganss to continue her world-leading work in reversing blood vessel growth in cancer tumors.
  • Deputy Director Professor John Olynyk to study the genetics of hemochromatosis, a common iron overload condition.
  • Deputy Director Professor Peter Thompson for research aimed at easing the burden of atherothombotic disease.


'/>"/>

Contact: Sarah Hayward
sarah@capturemedia.com.au
61-411-404-415
Research Australia
Source:Eurekalert

Related medicine news :

1. Shengtai Pharmaceutical Expands International Sales Program
2. Radiation Oncology Experts from 16 Countries Attend Technical University of Munich's International Conference on TomoTherapy
3. Susan G. Komen for the Cure(R) Strengthens Global Mission With Addition of Vice President, International
4. PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services
5. Guardian Provides National Access to In-Network Medical Benefits
6. Celebrity Cosmetic Dentist to Guest Co-Host New National Day Time Talk Show
7. New Program Internationalizes Health and Fitness Research
8. SkinMedica Hosts Aesthetics Division National Sales Meeting
9. uKarma Reports Progress With International Distribution Agreement for Its Xflowsion DVD Series
10. National Patient Advocate Foundation (NPAF) Commends SSAs New Compassionate Allowances Process
11. Animal Health International, Inc. Announces Its First Quarter Fiscal Year 2009 Earnings Release Date and Conference Call Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel ... a portion of proceeds to two local organizations: North Chicago Animal Control and Friends ... is a team of authorized and trained volunteers who support rescued animals held ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... "ProBrand Flip ... and all media," said Christina Austin - CEO of Pixel Film Studios. , ProBrand ... easy to use drop zones. Editors can select from a variety of flip book ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Tomorrow Trump Goes To Washington”: a ... to the presidency and to America. “Tomorrow Trump Goes To Washington” is the creation ... she can for this country. , Nancy attributes her patriotic nature to her WWII ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... to present at the International Probiotic Association’s Washington DC workshop on November 2nd. ... to engage in dialog regarding probiotic dietary supplement regulations. , Dr. Leyer ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... because of a higher risk of serious health problems, such as cardiovascular illness, ... Dr. Peiman Soleymani of Beverly Hills Periodontics & Dental Implant Center notes that ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... WESTLAKE VILLAGE, Calif. , Dec. 6, ... a privately held, clinical-stage medical dermatology and ... Creabilis plc, a privately held specialty pharmaceutical ... for common inflammatory skin conditions, including psoriasis, ... terms of the agreement, Sienna will make ...
(Date:12/6/2016)... Calif. , Dec. 6, 2016  Regulus ... biopharmaceutical company leading the discovery and development of ... drug development candidates at its R&D day, held ... first candidate, RGLS5040, is an anti-miR targeting microRNA-27 ... second candidate, RGLS4326, is an anti-miR targeting microRNA-17 ...
(Date:12/6/2016)... - InMed Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: ... in the use of cannabinoids for the treatment ... 2015 InMed initiated its COPD program using its ... potential active compounds that can be useful for ... assays using human lung fibroblasts (HFL-1 cell line), ...
Breaking Medicine Technology: